litlas
Log inCreate account

Giuseppe Ippolito

Active 1987–2026

210
Papers
29,334
Citations
93
h-index
200
i10-index

Citations

Citations per year for Giuseppe Ippolito1987: 1 citations1988: 3 citations1990: 3 citations1991: 5 citations1992: 3 citations1993: 3 citations1994: 3 citations1995: 5 citations1996: 3 citations1997: 11 citations1998: 10 citations1999: 10 citations2000: 20 citations2001: 29 citations2002: 39 citations2003: 60 citations2004: 58 citations2005: 57 citations2006: 57 citations2007: 69 citations2008: 59 citations2009: 78 citations2010: 80 citations2011: 70 citations2012: 76 citations2013: 64 citations2014: 39 citations2015: 45 citations2016: 83 citations2017: 108 citations2018: 105 citations2019: 420 citations2020: 2,494 citations2021: 2,128 citations2022: 1,504 citations2023: 729 citations2024: 701 citations2025: 272 citations2026: 12 citations1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,659 citing papers, 17% of this breakdownChina: 1,353 citing papers, 8.6% of this breakdownItaly: 1,162 citing papers, 7.4% of this breakdownUnited Kingdom: 998 citing papers, 6.4% of this breakdownIndia: 672 citing papers, 4.3% of this breakdownGermany: 540 citing papers, 3.5% of this breakdownFrance: 456 citing papers, 2.9% of this breakdownCanada: 425 citing papers, 2.7% of this breakdownSpain: 400 citing papers, 2.6% of this breakdownAustralia: 351 citing papers, 2.2% of this breakdownBrazil: 334 citing papers, 2.1% of this breakdownIran: 324 citing papers, 2.1% of this breakdown
0%17%Other 38.2%

Institutions

Fields

  • Medicine69.9%
  • Biochemistry, Genetics and Molecular Biology8.1%
  • Immunology and Microbiology7.4%
  • Mathematics3.4%
  • Computer Science2.5%
  • Psychology1.6%
  • Other7.1%

Topics

  • COVID-19 Clinical Research Studies9.7%
  • SARS-CoV-2 and COVID-19 Research8.6%
  • Long-Term Effects of COVID-194.3%
  • COVID-19 epidemiological studies2.3%
  • Tuberculosis Research and Epidemiology2.2%
  • Mosquito-borne diseases and control1.8%
  • Other71.1%

Coauthors

All papers

Open in search
  1. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

    Authors: Evdoxia Kyriazopoulou, Garyphallia Poulakou, Haralampos Milionis, Symeon Metallidis, Georgios Adamis, Konstantinos Tsiakos, Archontoula Fragkou, Aggeliki Rapti, Christina Damoulari, Massimo Fantoni, Ioannis Kalomenidis, Georgios Chrysos, Andrea Angheben, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Μαρία Τσιλικά, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Evangelos Kostis, Lorenzo Dagna, Panagiotis Koufargyris, Katerina Dimakou, Spyridon Savvanis, Glykeria Tzatzagou, Maria Chini, Giulio Cavalli, Matteo Bassetti, Konstantina Katrini, Vasilios Kotsis, George Tsoukalas, Carlo Selmi, Ioannis A. Bliziotis, Michael Samarkos, Michael Doumas, Sofia Ira Ktena, Aikaterini Masgala, Ιlias Papanikolaou, Maria Kosmidou, Dimitra-Melia Myrodia, Aikaterini Argyraki, Chiara Simona Cardellino, Katerina Koliakou, Eleni-Ioanna Katsigianni, Vassiliki Rapti, Efthymia Giannitsioti, Antonella Cingolani, Styliani Micha, Karolina Akinosoglou, Orestis Liatsis-Douvitsas, Styliani Symbardi, Nikolaos Gatselis, Maria Mouktaroudi, Giuseppe Ippolito, Eleni Florou, Antigone Kotsaki, Mihai G. Netea, Jesper Eugen‐Olsen, Miltiades Kyprianou, Periklis Panagopoulos, George Ν. Dalekos, Evangelos J. Giamarellos‐Bourboulis - Nature Medicine 2021 cited by 539

  2. Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

    Authors: Alimuddin Zumla, Martin Rao, Robert S. Wallis, Stefan H. E. Kaufmann, Roxana Rustomjee, Peter Mwaba, Cristina Vilaplana, Dorothy Yeboah‐Manu, Jeremiah Chakaya, Giuseppe Ippolito, Esam I. Azhar, Michael Höelscher, Markus Maeurer - The Lancet Infectious Diseases 2016 cited by 377

  3. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

    Authors: David S.C. Hui, Esam I. Azhar, Tariq A. Madani, Francine Ntoumi, Richard Kock, Osman Dar, Giuseppe Ippolito, Timothy D. McHugh, Ziad A. Memish, Christian Drosten, Alimuddin Zumla, Eskild Petersen - International Journal of Infectious Diseases 2020 cited by 4,026

  4. Deep learning-based single image super-resolution for low-field MR brain images

    Authors: M. L. de Leeuw den Bouter, Giuseppe Ippolito, Thomas O’Reilly, Rob Remis, Martin B. van Gijzen, Andrew Webb - Scientific Reports 2022 cited by 84

  5. Chikungunya

    Authors: Francesco Vairo, Najmul Haider, Richard Kock, Francine Ntoumi, Giuseppe Ippolito, Alimuddin Zumla - Infectious Disease Clinics of North America 2019 cited by 202

  6. Antimicrobial resistance preparedness in sub-Saharan African countries

    Authors: Linzy Elton, Margaret J. Thomason, John Tembo, Thirumalaisamy P. Velavan, Srinivas Reddy Pallerla, Liã Bárbara Arruda, Francesco Vairo, Chiara Montaldo, Francine Ntoumi, Muzamil Mahdi Abdel Hamid, Najmul Haider, Richard Kock, Giuseppe Ippolito, Alimuddin Zumla, Timothy D. McHugh - Antimicrobial Resistance and Infection Control 2020 cited by 126

  7. Accuracy of EEG Biomarkers in the Detection of Clinical Outcome in Disorders of Consciousness after Severe Acquired Brain Injury: Preliminary Results of a Pilot Study Using a Machine Learning Approach

    Authors: Francesco Di Gregorio, Fabio La Porta, Valeria Petrone, Simone Battaglia, Silvia Orlandi, Giuseppe Ippolito, Vincenzo Romei, Roberto Piperno, Giada Lullini - Biomedicines 2022 cited by 87

  8. The Role of Alpha Oscillations among the Main Neuropsychiatric Disorders in the Adult and Developing Human Brain: Evidence from the Last 10 Years of Research

    Authors: Giuseppe Ippolito, Riccardo Bertaccini, Luca Tarasi, Francesco Di Gregorio, Jelena Trajkovic, Simone Battaglia, Vincenzo Romei - Biomedicines 2022 cited by 126

  9. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

    Authors: Simon Tiberi, Nelita du Plessis, Gerhard Walzl, M. Vjecha, Martin Rao, Francine Ntoumi, Sayoki Mfinanga, Nathan Kapata, Peter Mwaba, Timothy D. McHugh, Giuseppe Ippolito, Giovanni Battista Migliori, Markus Maeurer, Alimuddin Zumla - The Lancet Infectious Diseases 2018 cited by 391

  10. COVID-19 infection: the perspectives on immune responses

    Authors: Yufang Shi, Ying Wang, Changshun Shao, Jianan Huang, Jianhe Gan, Xiaoping Huang, Enrico Bucci, Mauro Piacentini, Giuseppe Ippolito, Gerry Melino - Cell Death and Differentiation 2020 cited by 1,681

  11. COVID-19, SARS and MERS: are they closely related?

    Authors: Nicola Petrosillo, Giulio Viceconte, Önder Ergönül, Giuseppe Ippolito, Eskild Petersen - Clinical Microbiology and Infection 2020 cited by 1,142

  12. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

    Authors: Emanuele Andreano, Emanuele Nicastri, Ida Paciello, Piero Pileri, Noemi Manganaro, Giulia Piccini, Alessandro Manenti, Elisa Pantano, Anna Kabanova, Marco Troisi, Fabiola Vacca, Dario Cardamone, Concetta De Santi, Jonathan L. Torres, Gabriel Ozorowski, Linda Benincasa, Hyesun Jang, Cecilia Di Genova, Lorenzo Depau, Jlenia Brunetti, Chiara Agrati, Maria Rosaria Capobianchi, Concetta Castilletti, Arianna Emiliozzi, Massimiliano Fabbiani, Francesca Montagnani, Luisa Bracci, Giuseppe A. Sautto, Ted M. Ross, Emanuele Montomoli, Nigel Temperton, Andrew B. Ward, Claudia Sala, Giuseppe Ippolito, Rino Rappuoli - Cell 2021 cited by 240

  13. Viral Hepatitis

    Authors: Simone Lanini, Andrew Ustianowski, Raffaella Pisapia, Alimuddin Zumla, Giuseppe Ippolito - Infectious Disease Clinics of North America 2019 cited by 159

  14. Immune response in COVID-19: what is next?

    Authors: Qing Li, Ying Wang, Qiang Sun, Jasmin Knopf, Martin Herrmann, Liangyu Lin, Jingting Jiang, Changshun Shao, Peishan Li, Xiaozhou He, Fei Hua, Zubiao Niu, Chaobing Ma, Yichao Zhu, Giuseppe Ippolito, Mauro Piacentini, Jérôme Estaquier, Sonia Melino, Felix D. Weiss, Emanuele Andreano, Eicke Latz, Joachim L. Schultze, Rino Rappuoli, Alberto Mantovani, Tak W. Mak, Gerry Melino, Yufang Shi - Cell Death and Differentiation 2022 cited by 137

  15. Immunological and inflammatory profiles in mild and severe cases of COVID-19

    Authors: Jin‐Wen Song, Chao Zhang, Xing Fan, Fan-Ping Meng, Zhe Xu, Peng Xia, Wen-Jing Cao, Tao Yang, Xiao-Peng Dai, Siyu Wang, Ruo-Nan Xu, Tian-Jun Jiang, Wen-Gang Li, Dawei Zhang, Peng Zhao, Ming Shi, Chiara Agrati, Giuseppe Ippolito, Markus Maeurer, Alimuddin Zumla, Fu‐Sheng Wang, Ji‐Yuan Zhang - Nature Communications 2020 cited by 434

  16. Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era

    Authors: Eskild Petersen, Ibrahim Abubakar, Chikwe Ihekweazu, David Heymann, Francine Ntoumi, Lucille Blumberg, Danny Asogun, Victor Mukonka, Swaib A. Lule, Matthew Bates, Isobella Honeyborne, Sayoki Mfinanga, Peter Mwaba, Osman Dar, Francesco Vairo, Maowia M. Mukhtar, Richard Kock, Timothy D. McHugh, Giuseppe Ippolito, Alimuddin Zumla - International Journal of Infectious Diseases 2018 cited by 196

  17. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

    Authors: Chiara Agrati, Alessandra Sacchi, Veronica Bordoni, Eleonora Cimini, Stefania Notari, Germana Grassi, Rita Casetti, Eleonora Tartaglia, Eleonora Lalle, Alessandra D’Abramo, Concetta Castilletti, Luisa Marchioni, Yufang Shi, Andrea Mariano, Jin‐Wen Song, Ji‐Yuan Zhang, Fu‐Sheng Wang, Chao Zhang, Gian María Fimia, Maria Rosaria Capobianchi, Mauro Piacentini, Andrea Antinori, Emanuele Nicastri, Markus Maeurer, Alimuddin Zumla, Giuseppe Ippolito - Cell Death and Differentiation 2020 cited by 243

  18. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)

    Authors: Małgorzata Mikulska, Simone Lanini, Carlota Gudiol, Ľuboš Drgoňa, Giuseppe Ippolito, Mario Fernández‐Ruiz, Bernd Salzberger - Clinical Microbiology and Infection 2018 cited by 202

  19. The CLASSIC Knowledge Representation System: Implementation, Applications, and Beyond

    Authors: Rita Carsetti, Salvatore Zaffina, Eva Piano Mortari, Sara Terreri, Francesco Corrente, Claudia Capponi, Patrizia Palomba, Mattia Mirabella, Simona Cascioli, Paolo Palange, Ilaria Cuccaro, Cinzia Milito, Alimuddin Zumla, Markus Maeurer, Vincenzo Camisa, M. Vinci, Annapaola Santoro, Eleonora Cimini, Luisa Marchioni, Emanuele Nicastri, Fabrizio Palmieri, Chiara Agrati, Giuseppe Ippolito, Ottavia Porzio, Carlo Concato, Andrea Onetti Muda, Massimiliano Raponi, Concetta Quintarelli, Isabella Quinti, Franco Locatelli - Description Logics 1991 cited by 201

  20. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis

    Authors: Roberta Nardacci, Francesca Colavita, Concetta Castilletti, Daniele Lapa, Giulia Matusali, Silvia Meschi, Franca Del Nonno, Daniele Colombo, Maria Rosaria Capobianchi, Alimuddin Zumla, Giuseppe Ippolito, Mauro Piacentini, Laura Falasca - Cell Death and Disease 2021 cited by 127

  21. A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure

    Authors: Denise M. Cardo, David H. Culver, Carol A. Ciesielski, Pamela U. Srivastava, Ruthanne Marcus, D. Abiteboul, J Heptonstall, Giuseppe Ippolito, Florence Lot, Penny S. McKibben, David M. Bell - New England Journal of Medicine 1997 cited by 1,213

  22. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

    Authors: Didier Raoult, Alimuddin Zumla, Franco Locatelli, Giuseppe Ippolito, Guido Kroemer - Cell Stress 2020 cited by 410

  23. Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies

    Authors: Carla Tortorella, Alessandra Aiello, Claudio Gasperini, Chiara Agrati, Concetta Castilletti, Serena Ruggieri, Silvia Meschi, Giulia Matusali, Francesca Colavita, Chiara Farroni, Gilda Cuzzi, Eleonora Cimini, Eleonora Tartaglia, Valentina Vanini, Luca Prosperini, Shalom Haggiag, S. Galgani, Maria Esmeralda Quartuccio, Andrea Salmi, Federica Repele, Anna Maria Gerarda Altera, Flavia Cristofanelli, Alessandra D’Abramo, Nazario Bevilacqua, Angela Corpolongo, Vincenzo Puro, Francesco Vaia, Maria Rosaria Capobianchi, Giuseppe Ippolito, Emanuele Nicastri, Delia Goletti, on behalf of the INMI COVID-19 Vaccine Study Group, Daniele Lapa, Massimo Francalancia, Aurora Bettini, Giulia Gramigna, Federica Forbici, Paola Gall`ı, Alessandra Marani, Adriano Possi, Andrea Capri, Annapaola Santoro, Nicoletta Orchi, Ornella Butera, Saeid Najafi Fard, Linda Petrone, Elisa Petruccioli - Neurology 2021 cited by 158

  24. Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics

    Authors: Fabrizio Cantini, Carlotta Nannini, Laura Niccoli, Linda Petrone, Giuseppe Ippolito, Delia Goletti - Mediators of Inflammation 2017 cited by 145